Landscapes / Targets
5-HT2A
12 drugs act on 5-HT2A, in 30 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs12
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Atypical antipsychotic |
AbbVie · Public ABBV |
Approved | 15 Dec 2026soonPhase 3 trial completes | ||
| Next date | 15 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Schizophrenia, Depression and 1 more | ||||
| Open drug page | |||||
Atypical antipsychotic |
Approved | 5 Apr 2027Phase 3 trial completes | |||
| Next date | 5 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Irritability Associated With Autism Spectrum Disorder, Major Depressive Disorder and 5 more | ||||
| Open drug page | |||||
Atypical antipsychotic |
Approved in other | Oct 2027Phase 3 trial completes | |||
| Next date | Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Major Depressive Disorder (MDD), Major Depressive Disorder With Psychotic Features | ||||
| Open drug page | |||||
Atypical antipsychotic |
Approved | Nov 2027Phase 3 trial completes | |||
| Next date | Nov 2027 · Phase 3 trial completes | ||||
| Also tested for | Schizophrenia, Bipolar I Disorder and 2 more | ||||
| Open drug page | |||||
— |
Approved | Feb 2028Phase 2 trial completes | |||
| Next date | Feb 2028 · Phase 2 trial completes | ||||
| Also tested for | Pharmakokinetic, Open Label and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 7 Jun 2027Phase 3 trial completes | |||
| Next date | 7 Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Major Depressive Disorder, Major Depressive Disorder (MDD) and 5 more | ||||
| Open drug page | |||||
— |
Phase 3 | Sep 2027Phase 3 trial completes | |||
| Next date | Sep 2027 · Phase 3 trial completes | ||||
| Also tested for | Generalized Anxiety Disorder, Major Depressive Disorder | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2027Phase 3 trial completes | |||
| Next date | Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Negative Symptoms of Schizophrenia | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2028Phase 2/3 trial completes | |||
| Next date | Jan 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Alzheimer's Disease Psychosis, Lewy Body Dementia Psychosis | ||||
| Open drug page | |||||
— |
Phase 3 | Nov 2028Phase 2/3 trial completes | |||
| Next date | Nov 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Treatment Resistant Depression, Major Depressive Disorder and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Schizophrenia | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Irritable Bowel Syndrome | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 12 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026